CEO Total Pay
$20.8M
FY2023 Summary Compensation
Open-data reference.
DOW INC., a chemicals & pharmaceuticals company, reported a CEO-to-worker pay ratio of 220:1 in FY2023. CEO received total compensation of $20.8M, while the median employee earned $94,600 annually. This is above the Chemicals & Pharmaceuticals industry median of 44:1 across 185 companies. Data sourced from SEC EDGAR proxy (DEF 14A) filings.
Detailed breakdown not available.
| Component | Amount (USD) |
|---|---|
| Base Salary | — |
| Bonus | — |
| Stock Awards | — |
| Option Awards | — |
| Non-Equity Incentive Plan | — |
| Pension Value Change | — |
| Other Compensation | — |
| Total Compensation | $20.8M |
Source: SEC EDGAR Form DEF 14A — CIK 1751788, FY2023 Summary Compensation Table.
DOW INC.'s CEO-to-worker pay ratio of 220:1 means that earned 220 times more than the company's median employee in FY2023.
The median employee at DOW INC. earned $94,600 annually. At that wage, it would take a median employee approximately 220 years to earn what the CEO earned in a single year.
CEO Total Pay
$20.8M
FY2023 Summary Compensation
Pay Ratio
220:1
Elevated vs peers
Disclosure Transparency
1.0/5
Limited pay component reporting
Under 17 CFR §229.402(v) (the Pay-Versus-Performance rule effective for fiscal years ending after December 16, 2022), issuers must reconcile Compensation Actually Paid (CAP) to Total Shareholder Return (TSR) over a multi-year window. The chart below visualizes the relationship between DOW INC.'s reported CAP and TSR for FY2023.
ISS QualityScore and Glass-Lewis voting guidelines weight performance-linked share of pay. The CII (Council of Institutional Investors) recommends ≥50% of CEO pay be tied to multi-year performance metrics.
According to the 2023 DEF 14A proxy statement filed with the SEC, DOW INC. (DOW, CIK 1751788) reported CEO 's total compensation at $20.8M. That figure is an aggregate of base salary (N/A). The median employee at the firm — the reference point mandated by Section 953(b) of the Dodd-Frank Act — earned $94,600 over the same fiscal year, producing the headline CEO-to-worker pay ratio of 220:1 that this page tracks.
Context matters when reading this ratio. DOW INC. operates in the Chemicals & Pharmaceuticals sector and is headquartered in DE. Across the Chemicals & Pharmaceuticals industry (SIC 28), 185 SEC-reporting companies disclosed pay ratios in FY2023, with a median of 44:1 and an average of 90:1. Median industry CEO pay was $7.8M, so DOW INC.'s $20.8M sits above that typical figure. That comparison is the fastest way to separate "the CEO is paid like peers" from "this company is an outlier."
Finally, a note on what these SEC numbers do and do not include. Total compensation reported under Item 402 of Regulation S-K reflects grant-date fair value for equity awards, not realized pay, so a CEO may eventually cash in more — or less — depending on stock performance and vesting. The pay ratio itself is calculated against a single median employee chosen under rules that allow statistical sampling, and companies may update methodology year to year. This proxy was filed on 2024-03-01; all figures on this page come directly from that public filing and can be verified against the DEF 14A on the SEC EDGAR system.
Read our methodology — how this data is sourced, computed, and verified.